HealthQuill Health
One in seven people in the US has had long Covid by the end of 2022, according to a study by British and American researchers.
Drugs Health Pharma

One in seven people in US reports having long Covid by the end of 2022

HQ Team November 6, 2023: One in seven people in the US has had long Covid by the end of 2022, according to.

Read More
Chicago University researchers develop Inverse vaccine for autoimmune diseases
Drugs Health Pharma

Zoliflodacin shows potential in treating drug-resistant super gonorrhea

HQ Team November 4, 2023: Scientists have discovered a possible treatment for antibiotic-resistant super gonorrhea. In a large experiment involving nearly a 1000.

Read More
Drugs Health Medical

Novel long-acting GLP-1 agonist offers hope for type 2 diabetics

HQ Team November 4, 2023: Scientists at the University of Tabriz, Iran, have done pioneering work on a long-acting GLP-1 agonist that holds.

Read More
https://oag.ca.gov/news/press-releases/attorney-general-bonta-sues-nations-largest-insulin-makers-pharmacy-benefit
Drugs Health Medical Pharma

Study finds insulin can be stored at room temp without losing potency

HQ team November 3, 2023: Recent research by Cochrane has found that insulin can maintain its efficacy for extended periods at room temperature..

Read More
Biomedical engineers at Johns Hopkins have developed a machine-learning model, which can turn on genes —an innovation which in future can fight cancer and diabetes.
Drugs Health Medical

Key metabolite’s role in DNA repair will help cancer treatment

HQ team November 3, 2023: Researchers at Michigan Medicine, University of Michigan, have discovered a key metabolite’s role in regulating DNA repair processes,.

Read More
US-based Verrica Pharmaceuticals, a dermatology therapeutics company, has got FDA approval for a drug to treat a contagious viral skin disease, the company announced.
Drugs Health Medical

Researchers create synthetic melanin that heals burn injuries and beyond

HQ team November 3, 2023: Researchers at Northwestern University have developed a synthetic melanin, a versatile pigment found in nature. This synthetic version.

Read More
GSK, a British pharmaceutical company, will pay $1 billion to Johnson & Johnson for transferring exclusive global rights to develop and commercialise the US company’s hepatitis B therapy.
Drugs Health Pharma

GSK to pay $1 billion to acquire exclusive rights for J&J hepatitis B therapy

 HQ Team November 1, 2023: GSK, a British pharmaceutical company, will pay $1 billion to Johnson & Johnson for transferring exclusive global rights.

Read More
AstraZeneca signed a $245 million deal with a French clinical-stage biotechnology firm, Cellectis, to speed up therapeutics in oncology, immunology and rare diseases.
Drugs Health Pharma

AstraZeneca inks $245 million deal with Cellectis for rare diseases

HQ Team November 1, 2023: AstraZeneca signed a $245 million deal with a French clinical-stage biotechnology firm, Cellectis, to speed up therapeutics in.

Read More
The US’s medical research agency has discovered more than 3,000 new types of brain cells in different clusters of the organ that may help in the treatment of cancer and neurodegenerative diseases.
Drugs Health Pharma

NIH researchers find 3,000 new brain cells, create ‘most detailed’ atlas

HQ Team November 1, 2023: The US’s medical research agency has discovered more than 3,000 new types of brain cells in different clusters.

Read More
The US Food and Drug Administration has warned consumers not to use certain over-the-counter eye drop products due to the potential risk of infections.
Drugs Health Pharma

FDA warns against use of certain OTC eye drop products

HQ Team October 31, 2023: The US Food and Drug Administration has warned consumers not to use certain over-the-counter eye drop products due.

Read More